The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...

Xinjiang’s strategic role in the Belt and Road Initiative has also led to demographic engineering, as Beijing resettles Han ...

March 10, 2025 • 21:16 I’m a Transgender Colonel. Trump Wants Me Out. March 13, 2025 • 10:36 They Saved Taxpayers Billions.

Jacobio Pharma (1167.HK) released its 2024 annual results, with revenue of RMB160 million, R&D expense of RMB330 million. Major operating and financing activities generated RMB320 million cash inflows ...

Q4 2024 Earnings Call Transcript March 17, 2025 FibroGen, Inc. reports earnings inline with expectations. Reported EPS is $-0 ...

Discover masterful storytelling in collections that bring together SBS On Demand's TV dramas, movies and more in 16 different ...

Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...

IBS is a chronic gastrointestinal disorder affecting 10-15% people globally with symptoms like abdominal pain, bloating, constipation, and diarrhea. Misunderstood and stigmatized, this condition ...

The Union of Nigerian Bilateral Education Agreement Scholars (UNBEAS) has urged the federal government to address the delayed stipends and ...

Need a little drama in your life? We've got you covered. From family sagas to romantic epics, these librarian-recommended ...

EDMONTON - Alberta Premier Danielle Smith says plans for cleaning up abandoned or inactive oil wells are to be made public in ...

Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal ...